The effects of immune checkpoint inhibitors vs. chemotherapy combined with brain radiotherapy in non-small cell lung cancer patients with brain metastases
The study suggests that the combination of ICIs and brain radiotherapy provides superior OS for NSCLC patients with BM, compared to the chemotherapy combined with brain radiotherapy.
Authors
- Rumeng Li (ORCID: https://orcid.org/0000-0001-7735-6089)
- Conghua Xie (ORCID: https://orcid.org/0000-0002-9324-8683)
- Wen Ouyang (ORCID: https://orcid.org/0000-0001-7106-9302)
- Qiuji Wu (ORCID: https://orcid.org/0000-0002-4655-3108)
- Tengfei Wang (ORCID: https://orcid.org/0000-0002-1253-0514)
- Shuyan Liu (ORCID: https://orcid.org/0000-0002-5932-4857)
Institutions
- Wuhan University (CN)
- Zhongnan Hospital of Wuhan University (CN)
- Wuhan Sixth Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1186/s12885-024-13110-y
- Citations
- 2
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- Bethune Charitable Foundation
- Health Commission of Hubei Province
- National Natural Science Foundation of China
- Wuhan University
- Chinese Society of Clinical Oncology
- Servier
- Zhongnan Hospital of Wuhan University